| Jordan Knutson-steele, | |
|
20 E Piccadilly St Ste 11&14, Winchester, VA 22601-3971 | |
| (877) 407-3422 | |
| (877) 407-4329 |
| Full Name | Jordan Knutson-steele |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 20 E Piccadilly St Ste 11&14, Winchester, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306599436 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2202004276 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jordan Knutson-steele, 7 Carnegie Plz, Cherry Hill, NJ 08003-1000 Ph: (877) 407-3422 | Jordan Knutson-steele, 20 E Piccadilly St Ste 11&14, Winchester, VA 22601-3971 Ph: (877) 407-3422 |
News Archive
Research suggests that assessment of physical activity level should evaluate a person's overall level of moderate or vigorous activity as well as their amount of sedentary time to get an accurate estimate.
Ocera Therapeutics, Inc. announced today that it has completed two studies evaluating the safety and pharmacokinetics of OCR-002 (ornithine phenylacetate) which includes healthy volunteers and patients with liver cirrhosis. OCR-002 recently received Orphan Drug status and Fast Track designation by the United States Food and Drug Administration for the treatment of hyperammonemia (excessive ammonia levels) and resultant Hepatic encephalopathy.
At its annual meeting today with the investment community, Eli Lilly and Company highlighted how its innovation-based strategy will enable it to better serve patients and compete effectively in a challenging health care environment. The company also detailed the progress being made in its labs and across its five new business units on an expanding pipeline of innovative molecules and marketed medicines, and provided investors with the company's financial guidance for 2010.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces the publication of an article, entitled "A novel treatment for metastatic melanoma with intralesional rose bengal and radiotherapy: a case series," authored by Dr. Matthew C. Foote, Dr. Bryan H. Burmeister, Janine Thomas, and Dr. B. Mark Smithers, in the current issue of the peer-reviewed journal, Melanoma Research (20(1):48-51, February 2010).
› Verified 2 days ago
Diane Mcdaniels, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 146 Meadow Ln, Winchester, VA 22602 Phone: 540-662-4520 | |
Jessica Jones, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 380 Millwood Ave, Winchester, VA 22601 Phone: 540-667-7010 | |
Lila Griffith, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 638 Treys Dr, Winchester, VA 22601 Phone: 540-336-8031 | |
Dr. Donna M. Treiber, PH.D. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 105 Fairfield Dr, Winchester, VA 22602 Phone: 540-533-3829 | |
Hayley Getchell, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 Clocktower Ridge Dr, Winchester, VA 22603 Phone: 540-431-2800 | |
Kami Varner, MS,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 349 Apple Pie Ridge Rd, Winchester, VA 22603 Phone: 540-662-4781 | |
Mr. Robert John Franz Ii, M.ED.,CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1840 Amherst St, Winchester, VA 22601 Phone: 540-536-1126 Fax: 540-536-5139 |